Cargando…

Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View

To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miraglia Del Giudice, Michele, Licari, Amelia, Brambilla, Ilaria, Tosca, Maria Angela, Ciprandi, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346201/ https://www.ncbi.nlm.nih.gov/pubmed/32521598 http://dx.doi.org/10.3390/children7060058

Ejemplares similares

Allergen immunotherapy in children and adolescents with respiratory diseases
por: Tosca, Maria Angela, et al.
Publicado: (2020)

Intermittent and mild persistent asthma: how therapy has changed
por: Di Cicco, Maria Elisa, et al.
Publicado: (2021)

Immunotherapy and Asthma in Children
por: Tosca, Maria A., et al.
Publicado: (2018)

Asthma Endotyping and Biomarkers in Childhood Asthma
por: Licari, Amelia, et al.
Publicado: (2018)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents
por: Tosca, Maria Angela, et al.
Publicado: (2020)

Role of FEF(25-75) in managing children with newly-diagnosed asthma in clinical practice
por: Tosca, Maria A., et al.
Publicado: (2022)

Anxiety and depression in adolescents with asthma: a study in clinical practice
por: Licari, Amelia, et al.
Publicado: (2022)

Asthma in children and adolescents: the ControL’Asma project
por: Licari, Amelia, et al.
Publicado: (2020)

Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Anxiety in adolescents with severe asthma and response to treatment
por: Licari, Amelia, et al.
Publicado: (2020)

Resilience is low in adolescents with asthma and independent of asthma control
por: Marseglia, Gian Luigi, et al.
Publicado: (2022)

Characteristics of candidates for allergen immunotherapy
por: Ciprandi, Giorgio, et al.
Publicado: (2013)

Immunomodulation in Pediatric Asthma
por: Licari, Amelia, et al.
Publicado: (2019)

Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment
por: Licari, Amelia, et al.
Publicado: (2019)

Tablet allergen immunotherapy (TAIT) requires tight management
por: Ciprandi, Giorgio
Publicado: (2021)

Asthma control in adolescents: the importance of assessing adherence
por: Ciprandi, Giorgio, et al.
Publicado: (2022)

Agreements and controversies of national guidelines for bronchiolitis: Results from an Italian survey
por: Manti, Sara, et al.
Publicado: (2021)

Allergen specificity is relevant for immunotherapy prescription in polysensitised children
por: Ciprandi, Giorgio, et al.
Publicado: (2012)

Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population
por: Licari, Amelia, et al.
Publicado: (2018)

Probiotics in Children with Asthma
por: Ciprandi, Giorgio, et al.
Publicado: (2022)

Allergen-specific immunotherapy in pediatric allergic asthma
por: Yukselen, Ayfer
Publicado: (2016)

Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
por: Corsico, Angelo G., et al.
Publicado: (2019)

Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic
por: Cardinale, Fabio, et al.
Publicado: (2020)

Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma
por: Del Giudice, Michele Miraglia, et al.
Publicado: (2017)

Biologic drugs in chronic spontaneous urticaria
por: Licari, Amelia, et al.
Publicado: (2021)

Allergy and COVID-19
por: De Filippo, Maria, et al.
Publicado: (2021)

Allergen immunotherapy in asthma; what is new?
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Cetirizine use in childhood: an update of a friendly 30-year drug
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2020)

Cetirizine modifies quality of life and symptoms in children with seasonal allergic rhinitis: a pilot study
por: Benazzo, Marco, et al.
Publicado: (2021)

Allergen Immunotherapy in Asthma
por: Nakagome, Kazuyuki, et al.
Publicado: (2021)

Association between treatment awareness and uncontrolled asthma in adolescents
por: Castagnoli, Riccardo, et al.
Publicado: (2022)

An International Survey on the pragmatic management of epistaxis
por: Passali, Desiderio, et al.
Publicado: (2020)

Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics
por: Indinnimeo, Luciana, et al.
Publicado: (2018)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
por: Novembre, Elio, et al.
Publicado: (2022)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

Pediatric Asthma: A Daily Challenge
por: Ciprandi, Giorgio
Publicado: (2022)

Allergen Immunotherapy management during vaccinations: An international survey
por: Masieri, Simonetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ftk6mpodie237r3he28j336tvm